Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Zoetis
ZTS
$32.4B
| $107M | 0.08% |
780,597
-51,098
| -6% | -$6.67M |
|
177
CALL
Visa
V
$682B
| $107M | 0.08% |
553,600
-144,300
| -21% | -$26.4M |
|
178
Broadridge
BR
$17.7B
| $106M | 0.08% |
840,534
+43,644
| +5% | +$5.05M |
|
179
PUT
iShares MSCI Brazil ETF
EWZ
$9.29B
| $106M | 0.08% |
3,687,100
-973,400
| -21% | -$25.5M |
|
180
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.4B
| $106M | 0.08% |
5,588,400
+886,000
| +19% | +$16.5M |
|
181
PUT
Wells Fargo
WFC
$261B
| $106M | 0.08% |
4,122,100
+1,766,100
| +75% | +$48.3M |
|
182
Texas Instruments
TXN
$253B
| $104M | 0.08% |
822,277
-897,146
| -52% | -$105M |
|
183
GE Aerospace
GE
$374B
| $104M | 0.08% |
3,059,322
+894,296
| +41% | +$30.2M |
|
184
Regeneron Pharmaceuticals
REGN
$78B
| $104M | 0.08% |
166,848
+1,598
| +1% | +$907K |
|
185
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
| $104M | 0.08% |
1,508,557
+1,447,805
| +2,383% | +$93.9M |
|
186
MetLife
MET
$62.3B
| $103M | 0.08% |
2,831,803
+1,490,921
| +111% | +$51.9M |
|
187
Stellantis
STLA
$16.9B
| $102M | 0.08% |
9,964,081
+565,951
| +6% | +$4.89M |
|
188
Akamai
AKAM
$16.7B
| $102M | 0.08% |
950,892
+2,117
| +0.2% | +$213K |
|
|
XYZ
189
Block Inc
XYZ
$48.6B
| $102M | 0.08% |
968,894
-969,035
| -50% | -$74.2M |
|
190
Biogen
BIIB
$30.4B
| $101M | 0.08% |
379,009
-20,026
| -5% | -$6.02M |
|
191
Eli Lilly
LLY
$1.02T
| $101M | 0.08% |
615,946
-179,319
| -23% | -$27.5M |
|
192
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $100M | 0.08% |
920,000
+918,300
| +54,018% | +$95M |
|
193
US Bancorp
USB
$98.1B
| $100M | 0.08% |
2,728,838
-81,356
| -3% | -$2.9M |
|
194
iShares MSCI EAFE ETF
EFA
$78.1B
| $97.5M | 0.08% |
1,601,999
+209,516
| +15% | +$12.1M |
|
195
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $97.1M | 0.08% |
+1,175,000
| New | +$95.6M |
|
196
Vertex Pharmaceuticals
VRTX
$121B
| $96.7M | 0.07% |
333,092
-349,050
| -51% | -$94.6M |
|
|
B
197
Barrick Mining
B
$61.7B
| $96.1M | 0.07% |
3,565,725
-388,592
| -10% | -$9.71M |
|
198
TSMC
TSM
$2.11T
| $95.7M | 0.07% |
1,686,133
+27,031
| +2% | +$1.42M |
|
199
Mettler-Toledo International
MTD
$28.3B
| $95.2M | 0.07% |
118,196
-21,382
| -15% | -$15.9M |
|
200
Amphenol
APH
$199B
| $94.9M | 0.07% |
3,962,560
+245,188
| +7% | +$5.47M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.